Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment.

Research output: Contribution to journalLetter

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Hematology
Original languageEnglish
Pages (from-to)3473-3474
JournalBlood
Volume117
Issue number12
Publication statusPublished - 2011
Publication categoryResearch
Peer-reviewedYes